[cucumber3732842]

>Maybe he publishes and it goes somewhere, I have a feeling getting approval for trials will be challenging with his setup as it is now.

Yeah, drug development is one of those things where practically the only way to make it to production is to let a big incumbent with a big enough war chest to drag it across the finish line buy it.

[skeledrew]

If it isn't a potentially big money-maker said big incumbent won't touch it though. Will more likely try to shut it down especially if it overlaps with any of their more ludicrous offerings. And given the properties that this has (easy to manufacture, stable, soluble, low/no toxicity, etc) it's ripe for a shutdown because it'd make AD treatments far too cheap.

[CoastalCoder]

Any reason he couldn't try advancing it somewhere like China or India, which (I assume) are less vulnerable to that kind of interference?

[skeledrew]

China could be a good start, and given his name there could be some family connection he'd be able to take advantage of. But even if he's successful there there's nothing to stop Big Pharma from lobbying so it's either expensive to import or banned in the US/West.

[627467]

Big Pharma dynamics don't exist everywhere?